Clinical trial Recruiting at 1 site Interventional Ages 9 to 26

Family-based program to reduce risk factors for schizophrenia spectrum disorders in youth with family history

Official title: Developing Biomarker-Supported SSD Prevention

Run by The University of Texas Health Science Center, Houston · NCT07743645 · Data updated 2026-11-12

This study tests a brief family-based psychosocial program to see if it lowers persistent psychotic-like experiences in kids and young adults with a family history of SSD and different brain risk patterns.

Quick facts

Study typeInterventional
Ages9 Years to 26 Years
SexAll
Enrollment100 (estimated)
SponsorThe University of Texas Health Science Center, Houston
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedSeptember 1, 2026
Main results expectedApril 1, 2031
Study endsApril 1, 2031
Registry record updatedOctober 30, 2026
Trial IDNCT07743645 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are youths and young adults (9 to under 26) with a family history of SSD, at least two risk factors targeted by the intervention, and stable mental health on medication if applicable.

Probably not a fit

Individuals without a family history of SSD or without multiple targeted risk factors may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares a brief family-centered psychosocial intervention against no specified control to address modifiable risk factors for schizophrenia spectrum disorders. Participants are children and young adults aged 9 to under 26 with a family history of SSD and two or more targeted risk factors, and who are psychiatrically stable. The trial focuses on those with both high and low baseline SSD-like brain patterns to see if the intervention reduces distressing psychotic-like experiences. Recruitment is centered at The University of Texas Health Science Center, Houston, with NIH collaboration. Exclusion criteria include prior or current psychotic disorders or CHR-p, and recent changes in antipsychotic medications.

Why it matters

Potential benefit: If successful, participants may experience fewer distressing psychotic-like experiences and reduced risk factors associated with SSD.

How similar studies have gone: Past work suggests psychosocial interventions can influence risk-related factors in high-risk populations, though this specific family-based approach for SSD prevention is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Family history of SSD (defined as first-degree (e.g., a parent or a sibling), second-degree (e.g., an uncle or a grandparent), or other combinations of biological relatives in the family have or likely have a diagnosis of SSD or other closely related severe mental illnesses equivalent to at least 25% of genetic sharing) per medical record review and/or parent/legal guardian/self report and confirmed by a structured interview;
2. screening positive for two or more risk factors targeted by the intervention;
3. aged ≥ 9 and \<26 years of birthday;
4. Participants and parent(s)/legal guardian(s)/other family member(s) agree to participate;
5. psychiatrically stable and have no major changes in antidepressant, stimulant, or antipsychotic medication in the past 4 weeks.

Exclusion Criteria:

1. Current or past history of psychotic disorders or clinical high risk for psychosis (CHR-p) per study interview;
2. Current or past antipsychotic medication use to specifically treat a psychotic disorder;
3. major medical and neurological conditions;
4. moderate to severe intellectual disabilities or mild intellectual disabilities but expected to have difficulty completing the study assessments;
5. current drug or alcohol use that impacts functioning and study engagement;
6. Not able to give assent, permission, or consent;
7. Not able to undergo MRI.

Where it's running

  • The University of Texas Health Science Center at Houston
    Houston, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Yizhou Ma, PhD — The University of Texas Health Science Center, Houston
  • Study coordinator: Yizhou Ma, PhD
  • Email: Yizhou.Ma@uth.tmc.edu
  • Phone: 713-486-2740

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.